ID

29229

Descripción

Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00789191

Link

https://clinicaltrials.gov/show/NCT00789191

Palabras clave

Versiones (1)
  1. 10/3/18 10/3/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

10 de marzo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT00789191

Inglés

Eligibility Diabetes NCT00789191

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00789191
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed with type 2 diabetes for at least 6 months before trial start
Descripción

Non-Insulin-Dependent Diabetes Mellitus Disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
treatment with at least 1000 mg metformin per day for at least 3 months
Descripción

Metformin U/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0456683
insulin-naive (short-term insulin treatment of up to 14 days is allowed)
Descripción

Insulin naive | Insulin short-term allowed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
UMLS CUI [2,1]
C0021641
UMLS CUI [2,2]
C0443303
UMLS CUI [2,3]
C0683607
dpp-4 (dipeptidyl peptidase-4) inhibitor naive
Descripción

Dipeptidyl Peptidase-4 Inhibitor naive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3537225
UMLS CUI [1,2]
C0919936
hba1c (glycosylated haemoglobin a1c) between 7.5-10.0% by central laboratory analysis
Descripción

Glucohemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0202054
bmi (body mass index) lesser than or equal to 45.0 kg/m2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
able and willing to take one subcutaneous injection every day
Descripción

Subcutaneous Injections Quantity per day Able | Subcutaneous Injections Quantity per day Willing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021499
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0439505
UMLS CUI [1,4]
C0085732
UMLS CUI [2,1]
C0021499
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0439505
UMLS CUI [2,4]
C0600109
able and willing to perform mandatory smpg (self measured plasma glucose) measurements
Descripción

Plasma Glucose Measurement Self Able | Plasma Glucose Measurement Self Willing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0202042
UMLS CUI [1,2]
C0036588
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0202042
UMLS CUI [2,2]
C0036588
UMLS CUI [2,3]
C0600109
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy or intolerance to any of the trial products or related products
Descripción

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Intolerance to Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Pharmaceutical Preparations Related | Intolerance to Pharmaceutical Preparations Related

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0013230
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0013227
UMLS CUI [4,3]
C0439849
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0750491
UMLS CUI [5,3]
C0013227
UMLS CUI [5,4]
C0439849
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C0013227
UMLS CUI [6,3]
C0439849
severe hypertension
Descripción

Hypertension, severe

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4013784
treatment with thiazolidinedione (tzd) or glp-1 (glucagon-like peptide-1) analogues within 2 months prior to trial start
Descripción

Thiazolidinediones | GLP-1 Mimetics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257987
UMLS CUI [2]
C3273809
cardiac disease, within the last 12 months
Descripción

Heart Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018799
impaired hepatic function
Descripción

Liver Dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Descripción

Renal Insufficiency

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
proliferative retinopathy or macular oedema requiring acute treatment
Descripción

Proliferative retinopathy Treatment required for | Macular retinal edema Treatment required for

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0339467
UMLS CUI [1,2]
C0332121
UMLS CUI [2,1]
C0271051
UMLS CUI [2,2]
C0332121
female of childbearing potential
Descripción

Childbearing Potential

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3831118
known or suspected abuse of alcohol, narcotics or illicit substances
Descripción

Alcohol abuse | Narcotic Abuse | DRUG ABUSE ILLICIT | Alcohol abuse Suspected | Narcotic Abuse Suspected | DRUG ABUSE ILLICIT Suspected

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085762
UMLS CUI [2]
C0524661
UMLS CUI [3]
C0743253
UMLS CUI [4,1]
C0085762
UMLS CUI [4,2]
C0750491
UMLS CUI [5,1]
C0524661
UMLS CUI [5,2]
C0750491
UMLS CUI [6,1]
C0743253
UMLS CUI [6,2]
C0750491
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT00789191

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00789191
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
diagnosed with type 2 diabetes for at least 6 months before trial start
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Metformin U/day
Item
treatment with at least 1000 mg metformin per day for at least 3 months
boolean
C0025598 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
Insulin naive | Insulin short-term allowed
Item
insulin-naive (short-term insulin treatment of up to 14 days is allowed)
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2,1])
C0443303 (UMLS CUI [2,2])
C0683607 (UMLS CUI [2,3])
Dipeptidyl Peptidase-4 Inhibitor naive
Item
dpp-4 (dipeptidyl peptidase-4) inhibitor naive
boolean
C3537225 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hba1c (glycosylated haemoglobin a1c) between 7.5-10.0% by central laboratory analysis
boolean
C0202054 (UMLS CUI [1])
Body mass index
Item
bmi (body mass index) lesser than or equal to 45.0 kg/m2
boolean
C1305855 (UMLS CUI [1])
Subcutaneous Injections Quantity per day Able | Subcutaneous Injections Quantity per day Willing
Item
able and willing to take one subcutaneous injection every day
boolean
C0021499 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0439505 (UMLS CUI [1,3])
C0085732 (UMLS CUI [1,4])
C0021499 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0439505 (UMLS CUI [2,3])
C0600109 (UMLS CUI [2,4])
Plasma Glucose Measurement Self Able | Plasma Glucose Measurement Self Willing
Item
able and willing to perform mandatory smpg (self measured plasma glucose) measurements
boolean
C0202042 (UMLS CUI [1,1])
C0036588 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0202042 (UMLS CUI [2,1])
C0036588 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs | Intolerance to Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related | Hypersensitivity Suspected Pharmaceutical Preparations Related | Intolerance to Pharmaceutical Preparations Related
Item
known or suspected allergy or intolerance to any of the trial products or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
C1744706 (UMLS CUI [3,1])
C0013230 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0013227 (UMLS CUI [4,2])
C0439849 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C0750491 (UMLS CUI [5,2])
C0013227 (UMLS CUI [5,3])
C0439849 (UMLS CUI [5,4])
C1744706 (UMLS CUI [6,1])
C0013227 (UMLS CUI [6,2])
C0439849 (UMLS CUI [6,3])
Hypertension, severe
Item
severe hypertension
boolean
C4013784 (UMLS CUI [1])
Thiazolidinediones | GLP-1 Mimetics
Item
treatment with thiazolidinedione (tzd) or glp-1 (glucagon-like peptide-1) analogues within 2 months prior to trial start
boolean
C1257987 (UMLS CUI [1])
C3273809 (UMLS CUI [2])
Heart Disease
Item
cardiac disease, within the last 12 months
boolean
C0018799 (UMLS CUI [1])
Liver Dysfunction
Item
impaired hepatic function
boolean
C0086565 (UMLS CUI [1])
Renal Insufficiency
Item
impaired renal function
boolean
C1565489 (UMLS CUI [1])
Proliferative retinopathy Treatment required for | Macular retinal edema Treatment required for
Item
proliferative retinopathy or macular oedema requiring acute treatment
boolean
C0339467 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C0271051 (UMLS CUI [2,1])
C0332121 (UMLS CUI [2,2])
Childbearing Potential
Item
female of childbearing potential
boolean
C3831118 (UMLS CUI [1])
Alcohol abuse | Narcotic Abuse | DRUG ABUSE ILLICIT | Alcohol abuse Suspected | Narcotic Abuse Suspected | DRUG ABUSE ILLICIT Suspected
Item
known or suspected abuse of alcohol, narcotics or illicit substances
boolean
C0085762 (UMLS CUI [1])
C0524661 (UMLS CUI [2])
C0743253 (UMLS CUI [3])
C0085762 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0524661 (UMLS CUI [5,1])
C0750491 (UMLS CUI [5,2])
C0743253 (UMLS CUI [6,1])
C0750491 (UMLS CUI [6,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial